Frequency and clinical features of BRAF mutations among patients with stage III/IV lung adenocarcinoma without EGFR/ALK aberrations

PURPOSE: BRAF mutations are found in 1–5% of non-small cell lung cancers, particularly adenocarcinomas. However, information regarding this mutation is limited in patients without EGFR/ALK aberrations, who have limited treatment options. PATIENTS AND METHODS: The medical records of 224 stage III/IV...

Descripción completa

Detalles Bibliográficos
Autores principales: Kim, Ho Cheol, Kang, Yeh Rim, Ji, Wonjun, Kim, Yeon Joo, Yoon, Shinkyo, Lee, Jae Cheol, Choi, Chang-Min
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2019
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6666367/
https://www.ncbi.nlm.nih.gov/pubmed/31440061
http://dx.doi.org/10.2147/OTT.S213928

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6666367/
https://www.ncbi.nlm.nih.gov/pubmed/31440061
http://dx.doi.org/10.2147/OTT.S213928

Ejemplares similares